1-(tetrahydro-2H-pyran-4-yl)piperazine dihydrochloride hydrate, 95.0%, 250mg

Recipiente de cristalización ROTILABO® con pico, 150 ml, 80 mm, 10 Unidad(es)

6-Bromo-8-methoxy-[1,2,4]triazolo[4,3-a]pyrazine, 97%, 1g

(3-Aminobenzofuran-2-yl)(p-tolyl)methanone, 95.0%, 1g

H-D-Glu(OMe)-OH, 95.0%, 100g

(R)-2-((R)-2-Amino-3-phenylpropanamido)-3-phenylpropanoic acid, 95.0%, 250mg

5-Bromo-1H-pyrrolo[3,2-b]pyridin-2(3H)-one, 95.0%, 250mg

ELACRIDAR, 95%, 100mg

2-Chloro-5-fluoro-3-methylphenylboronic acid, 95%, 1g

1-(6-(Dimethylamino)naphthalen-2-yl)propan-1-one, 95.0%, 5g

N-[5-(Trifluoromethyl)pyrid-2-yl]-N-methyl-hydrazine, 95.0%, 1g

2,4-DIFLUORO-5-NITROBENZALDEHYDE, 95%, 10g

1-{1-[(2-Fluorophenyl)methyl]-1H-pyrazol-5-yl}methanamine hydrochloride, 1g